IMMU – Last Week’s Best PowerRatings Stock
Today’s
PowerRatings article looks at the best performing stock for the past five
days: Immunomedics
(
IMMU |
Quote |
Chart |
News |
PowerRating).
For
aggressive traders and investors, some of the biggest moves on a percentage
basis come from low-priced stocks. If you are willing to assume more risk, you
will find ample opportunities in low-priced stocks with high PowerRatings.
The chart below shows that IMMU had been sliding
for 3 straight sessions between 12/28/06 – 1/03/07. This coincided with a
PowerRating of
8 on 1/03/07 suggesting it was likely to outperform the S&P 500 over
the next five days.
PowerRatings performance shows the returns versus
the S&P 500 for the equivalent 5-day hold. The stocks which have had a PowerRating of 8 have outperformed the S&P 500 index on average over the next 5
days by an 5.8-1 margin. Stocks with a PowerRating of 9 have outperformed by a
10.1-1 margin. Stocks with a PowerRating of 10 have outperformed the S&P by
nearly 14.7-1 margin. This potential edge opens up a number of possibilities for
your trading and investing.
One more interesting fact about the
PowerRatings; PowerRatings of 1 and 2 have on average lost money over the next
week. A PowerRating of 1 has underperformed the S&P 500 by a 5-1 margin.
Obviously, you should ideally be looking to be buying high PowerRating stocks
and avoid (or short) low PowerRatings stocks.
Over the next five sessions
IMMU gained 17.27%.
Click here to start a free trial to PowerRatings and find stocks which have
historically outperformed the market.
Attend a free class on how to use
PowerRatings, presented by Steve Primo, our Director of Education.
Darren Wong
Associate Editor
Would you like to receive PowerRatings for full month for free? Send us your
PowerRatings strategy and if we accept it for publication, you will receive one
free month of unlimited access to PowerRatings. If you are already a monthly or
annual PowerRatings subscriber, you will receive an additional three months if
we publish your strategy.
Reminder: We are in no way recommending the purchase or short sale of these
stocks. This article is intended for education purposes only. Trading should be based on your own understanding of market conditions,
price patterns and risk; our information is designed to contribute to your
understanding.